ABSTRACT
The cysteine-rich region (CRR) of the integrin beta subunits is organised into four repeating elements. By expression of a panel of truncated beta 2 subunits, and CRR segments fused to the C-terminal end of a CD4 soluble fragment, the segment required for the expression of two monoclonal antibody conformational epitopes was determined. This segment, E482-Q574, contains 16 cysteines representing two repeating units. We have thus defined the CRR unit motif of 'xC---C---C---CxCxxCxC---Cx', where 'x' represents a single residue, and '---' represents a stretch of four to 14 residues.
Subject(s)
CD18 Antigens/immunology , Epitopes/chemistry , Recombinant Fusion Proteins/immunology , Repetitive Sequences, Amino Acid , Amino Acid Sequence , Animals , Antibodies, Monoclonal , CD18 Antigens/genetics , CD4 Antigens/genetics , CD4 Antigens/metabolism , COS Cells , Cysteine , Molecular Sequence Data , Recombinant Fusion Proteins/geneticsABSTRACT
An unusual CD18 monoclonal antibody (mAb) MEM-148 binds, in contrast to standard CD18 mAbs, specifically to peripheral blood monocytes and neutrophils activated by various stimuli such as phorbol myristate acetate, opsonized zymosan, heat-aggregated immunoglobulin, and (after priming with lipopolysaccharide, tumor necrosis factor, or granulocyte-macrophage colony-stimulating factor) also by formyl-methionyl-leucyl-phenylalanine. In addition, in vivo activated neutrophils obtained from urine of patients following recent prostatectomy were also strongly positive for MEM-148. On the activated myeloid cells the mAb recognized a 65- to 70-kd protein identified immunochemically and by mass spectrometric peptide sequencing as a membrane-anchored fragment of CD18 (the common chain of leukocyte integrins) produced by proteolytic cleavage. The CD18 fragment originated mainly from integrin molecules stored intracellularly in resting cells, it was unassociated with CD11 chains, and its formation was inhibited by several types of protease inhibitors. Thus, the 65- to 70-kd CD18 fragment represents a novel abundant activation marker of myeloid cells of so far unknown function but possibly involved in conformational changes in leukocyte integrin molecules resulting in increased affinity to their ligands.
Subject(s)
CD18 Antigens/metabolism , Epitopes/analysis , Myeloid Cells/chemistry , Peptide Fragments/analysis , Antibodies, Monoclonal/immunology , Antibody Specificity , Biomarkers , Blotting, Western , CD18 Antigens/chemistry , CD18 Antigens/immunology , Cell Adhesion , Electrophoresis, Gel, Two-Dimensional , Endopeptidases/metabolism , Epitopes/immunology , Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology , Humans , Immunoglobulin G/immunology , Immunoglobulin G/pharmacology , Lipopolysaccharides/pharmacology , Male , Mass Spectrometry , Monocytes/chemistry , Monocytes/drug effects , Myeloid Cells/drug effects , N-Formylmethionine Leucyl-Phenylalanine/pharmacology , Neutrophils/chemistry , Neutrophils/drug effects , Peptide Fragments/immunology , Tetradecanoylphorbol Acetate/pharmacology , Tumor Necrosis Factor-alpha/pharmacology , Zymosan/pharmacologyABSTRACT
In the primary sequence of the integrin beta subunit, the N-terminal region (NTR) and mid-region are separated by the I-like domain. To determine the spatial relationship and functional properties of the integrin beta(2) NTR and mid-region, we constructed beta(2)/beta(7) chimeras in which the NTR, I-like domain, and the mid-region of the beta(2) subunit were replaced by those of beta(7). Changing either the beta(2) NTR or mid-region, but not the I-like domain to that of beta(7) did not affect LFA-1 (alpha(L)beta(2)) formation and surface expression. Thus, the specificity of alpha(L)beta(2) pairing is conferred by the I-like domain but not the NTR or mid-region. Using these chimeras, the epitopes of six anti-beta(2) mAbs (H52, 7E4, AZN-L18, AZN-L27, KIM202, and MEM-148) were mapped. All except H52 require both the NTR and mid-region for epitope expression. Since these mAbs have distinct properties in terms of epitope expression and effect on LFA-1 binding to ICAM-1, we conclude that the beta(2) NTR and mid-region interact extensively. Although the I-like domain is located between the NTR and mid-region, its removal does not affect the folding of the beta(2) NTR/mid-region complex because this complex alone can be expressed as a soluble protein and precipitated by the appropriate mAbs. Finally, the mAbs H52 and 7E4, abrogated KIM185- but not Mg/EGTAinduced LFA-1/ICAM-1 binding and the epitope of MEM-148 is expressed on Mg/EGTA-activated but not resting LFA-1. These results suggest that the NTR/mid-region complex is involved in the regulation of LFA-1 function.
Subject(s)
CD18 Antigens/chemistry , Amino Acid Sequence , Animals , Antibodies, Monoclonal/chemistry , COS Cells , Cell Adhesion , DNA, Complementary/metabolism , Epitopes , Flow Cytometry , Gene Library , Humans , Intercellular Adhesion Molecule-1/metabolism , Lymphocyte Function-Associated Antigen-1/metabolism , Molecular Sequence Data , Precipitin Tests , Protein Binding , Protein Structure, Tertiary , TransfectionABSTRACT
Monoclonal antibody MEM-148 was previously shown to recognize CD18 chains in a free form unassociated within leukocyte integrin heterodimers, but yet it is paradoxically able to induce a high-affinity conformation in the native, cell surface expressed LFA-1 molecules. Our results based on kinetics of binding, immunoprecipitation and cell-aggregation experiments demonstrate that the mAb does bind to and stabilizes a specific conformation of LFA-1 heterodimers apparently distinguished by an increased affinity to its cellular ligand(s). A similar high-affinity conformation of LFA-1, in which the MEM-148 epitope becomes exposed, is induced also by a Mg2+/EDTA or low pH (5.5-6.5) treatments which may mimic physiologically relevant situations in normal or inflamed tissues. Thus, mAb MEM-148 is a novel valuable tool for detection and induction of specific conformations of human leukocyte integrins.
Subject(s)
Antibodies, Monoclonal , CD18 Antigens/immunology , Integrins/immunology , Leukocytes/immunology , Animals , CD18 Antigens/chemistry , Cell Aggregation , Epitopes/chemistry , Epitopes/immunology , Humans , Integrins/chemistry , Jurkat Cells , Kinetics , Lymphocyte Activation , Lymphocyte Function-Associated Antigen-1/chemistry , Lymphocyte Function-Associated Antigen-1/immunology , Mice , Models, Molecular , Protein ConformationABSTRACT
There is growing evidence that dipeptidyl peptidase IV [DPP-IV, EC 3.4.14.5] takes part in the metabolism of biologically active peptides participating in the regulation of growth and transformation of glial cells. However, the knowledge on the DPP-IV expression in human glial and glioma cells is still very limited. In this study, using histochemical and biochemical techniques, the DPP-IV activity was demonstrated in two commercially available human glioma cell lines of different transformation degree, as represented by U373 astrocytoma (Grade III) and U87 glioblastoma multiforme (Grade IV) lines. Higher total activity of the enzyme, as well as its preferential localisation in the plasma membrane, was observed in U87 cells. Compared to U373 population, U87 cells were morphologically more pleiomorphic, they were cycling at lower rate and expressing less Glial Fibrillary Acidic Protein. The data revealed positive correlation between the degree of transformation of cells and activity of DPP-IV. Great difference in expression of this enzyme, together with the phenotypic differences of cells, makes these lines a suitable standard model for further studies of function of this enzyme in human glioma cells.
Subject(s)
Dipeptidyl Peptidase 4/analysis , Glioma/enzymology , Cell Division , Cell Transformation, Neoplastic , DNA, Neoplasm/analysis , Flow Cytometry , Glial Fibrillary Acidic Protein/analysis , Glioma/pathology , Humans , Immunohistochemistry , Tumor Cells, CulturedABSTRACT
One of the recently described antigens broadly expressed on human leukocytes is CDw149, which was defined at the 6th Human Leukocyte Differentiation Antigen (HLDA) Workshop by means of 2 monoclonal antibodies (mAbs). Molecular characterization of this antigen has been lacking. In the present study we demonstrate that these anti-CDw149 mAbs actually recognize a clustered subset of a well-defined membrane protein, CD47, also known as integrin-associated protein (IAP). This clustered subset is present on leukocytes but not erythrocytes. The anti-CDw149 mAbs bind with only low affinity to a monomeric (unclustered) subset of CD47 but with high avidity to the CD47 clusters. A fraction of CD47 is associated with large complexes containing cytoplasmic signaling molecules (Src family kinases and heterotrimeric G-proteins) similar to glycosphingolipid-enriched microdomains (GEMs), which may explain the previously described signaling capacity of CD47. The low-affinity anti-CD47 mAbs may be useful tools targeting specific receptor complexes involved in cell activation. Specific reactivity of low-affinity mAbs with clustered subsets of cell surface antigens may more generally explain the nature of poorly defined "activation forms" or activation neoepitopes described previously for several cell surface molecules.
Subject(s)
Antibodies, Monoclonal/immunology , Antigens, CD/immunology , Carrier Proteins/immunology , Signal Transduction , Antibody Affinity , Antigens, CD/chemistry , CD47 Antigen , Carrier Proteins/chemistry , Cell Line , Cytoplasm/immunology , Erythrocytes/immunology , Humans , Jurkat Cells , Kinetics , Leukocytes/immunology , Macromolecular Substances , Membrane Proteins/immunology , Protein Structure, QuaternaryABSTRACT
Monoclonal antibodies to CD18, the common chain of leukocyte integrins, recognize in various types of human lymphoid and myeloid cells under the conditions of nonreducing Western blotting three species of CD18 of mol. wt. 96, 87, and 78 kDa, respectively. Using a unique monoclonal antibody MEM-148 reacts exclusively with free CD18 molecules, but not with leukocyte integrin heterodimers. We demonstrate that only the upper one (96 kDa) is present on the cell surface within the CD11/CD18 integrin heterodimers, while the lower ones (87 and 78 kDa) are found intracellularly as free molecules unassociated with CD11 chains or other molecules. These intracellular free CD18 chains may in part represent biosynthetic precursors; alternatively, these species may represent an intracellular source of the recently observed free, proteolytically truncated CD18 chains expressed on the surface of activated myeloid cells.
Subject(s)
CD18 Antigens/immunology , Leukocytes/immunology , Antibodies, Monoclonal/immunology , Cell Line , Epitopes/chemistry , Epitopes/immunology , Humans , Lymphocyte Function-Associated Antigen-1/immunology , Spectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationABSTRACT
According to a recently proposed hypothesis, initiation of signal transduction via immunoreceptors depends on interactions of the engaged immunoreceptor with glycosphingolipid-enriched membrane microdomains (GEMs). In this study, we describe a novel GEM-associated transmembrane adaptor protein, termed phosphoprotein associated with GEMs (PAG). PAG comprises a short extracellular domain of 16 amino acids and a 397-amino acid cytoplasmic tail containing ten tyrosine residues that are likely phosphorylated by Src family kinases. In lymphoid cell lines and in resting peripheral blood alpha/beta T cells, PAG is expressed as a constitutively tyrosine-phosphorylated protein and binds the major negative regulator of Src kinases, the tyrosine kinase Csk. After activation of peripheral blood alpha/beta T cells, PAG becomes rapidly dephosphorylated and dissociates from Csk. Expression of PAG in COS cells results in recruitment of endogenous Csk, altered Src kinase activity, and impaired phosphorylation of Src-specific substrates. Moreover, overexpression of PAG in Jurkat cells downregulates T cell receptor-mediated activation of the transcription factor nuclear factor of activated T cells. These findings collectively suggest that in the absence of external stimuli, the PAG-Csk complex transmits negative regulatory signals and thus may help to keep resting T cells in a quiescent state.
Subject(s)
Glycosphingolipids/metabolism , Lymphocyte Activation , Membrane Proteins/metabolism , Phosphoproteins/metabolism , Protein-Tyrosine Kinases/metabolism , T-Lymphocytes/immunology , Adaptor Proteins, Signal Transducing , Amino Acid Sequence , CD3 Complex/metabolism , CSK Tyrosine-Protein Kinase , Cloning, Molecular , DNA, Complementary/genetics , Humans , Membrane Proteins/genetics , Molecular Sequence Data , Phosphoproteins/genetics , Protein Binding , Receptors, Antigen, T-Cell/metabolism , Signal Transduction , src-Family KinasesABSTRACT
Glycosylphosphatidylinositol (GPI)-anchored proteins and glycosphingolipids are assembled on the leukocyte surface within membrane microdomains, which also accommodate a set of cytoplasmic signalling molecules (Src family kinases, G-proteins, linker proteins). Recent results suggest that these membrane specializations mediate not only signal transduction via GPI-proteins and glycolipids but also play important roles in initiation of signalling via immunoreceptors.
Subject(s)
Glycosylphosphatidylinositols/immunology , Receptors, Immunologic/metabolism , Animals , Cell Membrane/immunology , Humans , Leukocytes/immunology , Membrane Proteins/immunology , Models, Biological , Signal Transduction/immunologyABSTRACT
The CDw108 glycoprotein is expressed on the surface of some leukemic cell lines, erythrocytes and on activated lymphocytes. Its surface expression is rapidly upregulated following various activating stimuli (PHA, PWM, Con A, PMA, anti-CD3) and subsequently gradually decreases. The molecule is anchored in the membrane via glycosylphosphatidylinositol (GPI) moiety, it has molecular mass of 75-80 kDa and pI of 5.0-5.5. Endoglycosidase F and H reduce its apparent size as determined by SDS PAGE by approx. 15 and 22 kDa, respectively. It is a component of large, detergent-resistant GPI-complexes associated with protein kinases. In addition to the previously described identity of CDw108 with the JMH blood group antigen, we demonstrate here its identity to the previously described glycoprotein recognized by monoclonal antibodies H105 and KS.2, and exclude its identity with another GPI-anchored glycoprotein of similar size, melanotransferrin (gp97).
Subject(s)
Antigens, CD/chemistry , Glycosylphosphatidylinositols , Membrane Glycoproteins/chemistry , Semaphorins , Antigens, CD/biosynthesis , Antigens, CD/immunology , Antigens, Neoplasm , Antigens, Surface/biosynthesis , Antigens, Surface/chemistry , Antigens, Surface/immunology , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , GPI-Linked Proteins , Humans , Killer Cells, Natural/drug effects , Killer Cells, Natural/immunology , Leukocytes/drug effects , Leukocytes/immunology , Melanoma-Specific Antigens , Membrane Glycoproteins/biosynthesis , Neoplasm Proteins/biosynthesis , Neoplasm Proteins/chemistry , Neoplasm Proteins/immunology , T-Lymphocytes/drug effects , T-Lymphocytes/immunology , Tumor Cells, CulturedABSTRACT
A CDw78 mAb FN1 was shown to recognize DP and/or DR molecules under the conditions of Western blotting. DP molecules were specifically retarded on a column of the FN1 immunosorbent; binding of FITC-labeled FN1 to B cell lines was completely blocked by excess of mAb to DR/DP beta chains, partially by several mAb to DP and weakly by some mAb to DR. The binding of two other CDw78 mAb, FN4 and MR11, to the B cell surface was most strongly inhibited by excess of different mAb to DR. Kinetics of stable binding of the CDw78 mAb indicated that their monovalent binding is of low affinity and that the stable binding to the surface is due to bivalent binding to two spatially close MHC class II molecules. FN1-based immunosorbent effectively immunoisolated complexes of MHC class II proteins with several tetraspanin molecules from a mild detergent lysate of a B cell line. It is concluded that FN1 and most likely also the other two CDw78 mAb recognize with low affinity determinants on MHC class II molecules (DP or DR) and preferentially bind in a stable fashion to dimerized or aggregated MHC class II molecules. Such dimers or aggregates may either exist as preformed on the cell surface or may be gradually formed and stabilized by bivalent interaction with mAb. These structures may be related to the previously described 'superdimers' of MHC class II and/or 'MHC-tetraspanin complexes'. CDw78 mAb may be valuable tools targeting such aggregated fraction of MHC class II molecules which can exhibit important signaling and antigen-presenting properties.
Subject(s)
Antigens, CD/immunology , Epitopes/immunology , Histocompatibility Antigens Class II/immunology , Antibodies, Monoclonal/immunology , Blotting, Western , Chromatography, Affinity/methods , Flow Cytometry , HumansSubject(s)
Blood Cells/metabolism , Neprilysin/metabolism , Phosphoproteins/metabolism , src-Family Kinases/metabolism , Blood Cells/chemistry , Cell Membrane/chemistry , Cell Membrane/metabolism , Glycosylphosphatidylinositols , Humans , Membrane Proteins/chemistry , Membrane Proteins/metabolism , Neprilysin/chemistry , Phosphoproteins/chemistry , Phosphorylation , src-Family Kinases/chemistryABSTRACT
CD3delta-deficient (delta degrees) mice are defective in alphabeta T cell development. Here we explore the capacity of TCR-CD3 signaling complexes expressed on delta degrees thymocytes to mediate the following functional outcomes in response to antibody cross-linking: (i) the transition from the CD4-CD8- to CD4+CD8+ stage, (ii) the transition from the CD4+CD8+ to CD4+CD8- or CD4-CD8+ stages and (iii) the induction of apoptosis. We provide evidence that CD3deltaepsilon complexes are dispensable for mediating the anti-CD3-mediated CD4-CD8- to CD4+CD8+ transition. On the other hand, CD3delta is critical at the CD4+CD8+ stage. We demonstrate that CD4+CD8+ thymocytes from delta degrees mice, unlike delta degrees CD4-CD8- thymocytes and wild-type CD4+CD8+ thymocytes, require prolonged or consecutive stimuli to elicit functional responses. Depending on the nature of the secondary stimulus, delta degrees thymocytes can be induced to undergo apoptosis or preferential maturation to the CD4-CD8+ stage. Taken together these results indicate that the signaling capacity of the TCR-CD3 complex is noticeably altered in the absence of CD3delta. The essential role of CD3delta at the CD4+CD8+ stage of development correlates with the onset of TCRalpha rearrangement, consistent with a critical structural and/or functional relationship between CD3delta and TCRalpha.
Subject(s)
Receptor-CD3 Complex, Antigen, T-Cell/metabolism , T-Lymphocyte Subsets/physiology , Animals , Antibodies/pharmacology , Apoptosis/drug effects , CD3 Complex/immunology , CD3 Complex/physiology , CD4 Antigens/immunology , Cell Differentiation/drug effects , Cell Differentiation/immunology , Clonal Deletion/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Transgenic , Receptors, Antigen, T-Cell/immunology , Receptors, Antigen, T-Cell/physiology , Receptors, Antigen, T-Cell, alpha-beta/immunology , Superantigens/physiology , T-Lymphocyte Subsets/cytology , T-Lymphocyte Subsets/drug effects , Time FactorsABSTRACT
Membrane proteins anchored in the membrane via a glycolipid glycosylphosphatidylinositol (GPI) as well as some glycolipids are able to transduce signals and induce diverse functional responses in cells upon their cross-linking via antibodies or natural ligands. In some cases this signaling capacity seems to be due to associations of these molecules with specific transmembrane proteins. GPI-anchored proteins are components of membrane microdomains enriched in glycosphingolipids and cholesterol and devoid of most transmembrane proteins. These membrane specializations are relatively resistant to solubilization in solutions of some mild detergents at low temperatures. These 'GPI-microdomains' contain also cytoplasmic signaling molecules such as Src-family protein tyrosine kinases and trimeric G-proteins. Thus, at least some signaling elicited upon cross-linking of GPI-anchored proteins and glycolipids may be due to perturbation of the signaling molecules associated with these microdomains. It is suggested that these specialized areas of the membrane rich in signaling molecules interact with immunoreceptors (TCR, BCR, Fc receptors) cross-linked upon their interactions with ligands and importantly contribute to initiation of proximal phases of their signaling pathways.
Subject(s)
Glycosylphosphatidylinositols/physiology , Leukocytes/physiology , Receptors, Immunologic/physiology , Signal Transduction/physiology , Animals , HumansSubject(s)
Antibodies, Monoclonal , CD2 Antigens/immunology , Animals , COS Cells , Humans , Leukocytes/immunology , Mice , Mice, Inbred BALB C , Tumor Cells, CulturedSubject(s)
Digestive System/metabolism , Hemolysin Proteins/physiology , Hemolysis , Oligochaeta/immunology , Opsonin Proteins , Animals , Hemolysin Proteins/genetics , Hemolysin Proteins/isolation & purification , Molecular Weight , Oligochaeta/genetics , Oligochaeta/metabolism , Phagocytosis , Polyhydroxyethyl Methacrylate/metabolismABSTRACT
A diversity of high-affinity oligosaccharide ligands are identified for NKR-P1, a membrane protein on natural killer (NK) cells which contains an extracellular Ca(2+)-dependent lectin domain. Interactions of such oligosaccharides on the target cell surface with NKR-P1 on the killer cell surface are crucial both for target cell recognition and for delivery of stimulatory or inhibitory signals linked to the NK cytolytic machinery. NK-resistant tumour cells are rendered susceptible by preincubation with liposomes expressing NKR-P1 ligands, suggesting that purging of tumour or virally infected cells in vivo may be a therapeutic possibility.